Variant report

Variant	nsv877647
Chromosome Location	chr3:150609694-150641304
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:150641002-150641130	K562	blood:	n/a	n/a
2	BATF	chr3:150630310-150630553	GM12878	blood:	n/a	chr3:150630501-150630511 chr3:150630500-150630511
3	BATF	chr3:150630257-150630676	GM12878	blood:	n/a	chr3:150630501-150630511 chr3:150630500-150630511
4	BHLHE40	chr3:150639017-150639325	HepG2	liver:	n/a	n/a
5	CEBPB	chr3:150621795-150621811	Hela-S3	cervix:	n/a	chr3:150621801-150621810 chr3:150621800-150621811
6	CEBPB	chr3:150621673-150621946	HepG2	liver:	n/a	chr3:150621799-150621812 chr3:150621801-150621810 chr3:150621800-150621811
7	CEBPB	chr3:150621761-150621905	K562	blood:	n/a	chr3:150621799-150621812 chr3:150621801-150621810 chr3:150621800-150621811
8	CEBPB	chr3:150621740-150621837	A549	lung:	n/a	chr3:150621799-150621812 chr3:150621801-150621810 chr3:150621800-150621811
9	CEBPB	chr3:150630052-150630450	A549	lung:	n/a	chr3:150630344-150630355 chr3:150630344-150630357 chr3:150630346-150630355 chr3:150630346-150630355 chr3:150630344-150630357 chr3:150630346-150630355 chr3:150630346-150630355
10	CTCF	chr3:150636420-150636570	A549	lung:	n/a	chr3:150636491-150636509 chr3:150636486-150636507 chr3:150636493-150636506 chr3:150636492-150636508
11	CTCF	chr3:150639176-150639211	MCF-7	breast:	n/a	n/a
12	CTCF	chr3:150628577-150628632	GM20000	blood:	n/a	n/a
13	CTCF	chr3:150640598-150640640	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr3:150636432-150636514	MCF-7	breast:	n/a	chr3:150636491-150636509 chr3:150636486-150636507 chr3:150636493-150636506 chr3:150636492-150636508
15	CTCF	chr3:150636456-150636513	H1-hESC	embryonic stem cell:	n/a	chr3:150636491-150636509 chr3:150636486-150636507 chr3:150636493-150636506 chr3:150636492-150636508
16	CTCF	chr3:150636479-150636513	A549	lung:	n/a	chr3:150636491-150636509 chr3:150636486-150636507 chr3:150636493-150636506 chr3:150636492-150636508
17	CTCF	chr3:150639564-150639626	GM19239	blood:	n/a	n/a
18	CTCF	chr3:150640615-150640627	MCF-7	breast:	n/a	n/a
19	CTCF	chr3:150639174-150639218	GM19239	blood:	n/a	n/a
20	CTCF	chr3:150639144-150639224	H1-hESC	embryonic stem cell:	n/a	n/a
21	E2F4	chr3:150632628-150632687	MCF10A-Er-Src	breast:	n/a	n/a
22	E2F4	chr3:150640965-150641208	MCF10A-Er-Src	breast:	n/a	n/a
23	EP300	chr3:150630629-150630630	GM12878	blood:	n/a	n/a
24	FOS	chr3:150631207-150631380	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr3:150638074-150638320	MCF10A-Er-Src	breast:	n/a	chr3:150638204-150638215
26	FOS	chr3:150638044-150638321	MCF10A-Er-Src	breast:	n/a	chr3:150638204-150638215
27	FOS	chr3:150631234-150631321	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr3:150639126-150639361	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr3:150638033-150638633	MCF10A-Er-Src	breast:	n/a	chr3:150638204-150638215
30	FOS	chr3:150638861-150639396	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr3:150638025-150638357	MCF10A-Er-Src	breast:	n/a	chr3:150638204-150638215
32	FOS	chr3:150639087-150639401	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr3:150639087-150639381	MCF10A-Er-Src	breast:	n/a	n/a
34	FOXA1	chr3:150623651-150624072	T-47D	breast:	n/a	n/a
35	FOXA1	chr3:150626895-150627253	HepG2	liver:	n/a	n/a
36	FOXA1	chr3:150623597-150623990	T-47D	breast:	n/a	n/a
37	GATA1	chr3:150620802-150621192	PBDE	blood:	n/a	chr3:150620930-150620937 chr3:150620961-150620968 chr3:150620961-150620968 chr3:150620923-150620944 chr3:150620930-150620937 chr3:150620959-150620968 chr3:150620956-150620972 chr3:150620930-150620937 chr3:150620961-150620968
38	GATA2	chr3:150614233-150614646	SH-SY5Y	brain:	n/a	chr3:150614419-150614433
39	GATA2	chr3:150614266-150614505	HUVEC	blood vessel:	n/a	chr3:150614419-150614433
40	GATA3	chr3:150614280-150614601	T-47D	breast:	n/a	n/a
41	GATA3	chr3:150614351-150614538	SH-SY5Y	brain:	n/a	n/a
42	GATA3	chr3:150623614-150624213	T-47D	breast:	n/a	n/a
43	GATA3	chr3:150614222-150614655	MCF-7	breast:	n/a	n/a
44	GATA3	chr3:150623636-150624226	MCF-7	breast:	n/a	n/a
45	GATA3	chr3:150614190-150614752	MCF-7	breast:	n/a	n/a
46	GATA3	chr3:150623549-150624380	MCF-7	breast:	n/a	n/a
47	GATA3	chr3:150616615-150617098	T-47D	breast:	n/a	n/a
48	GATA3	chr3:150621140-150621433	SH-SY5Y	brain:	n/a	n/a
49	GATA3	chr3:150623337-150624515	MCF-7	breast:	n/a	chr3:150623406-150623413
50	GATA3	chr3:150614272-150614586	MCF-7	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:150621326-150621376	HPAEpiC	pulmonary alveolar:	n/a
2	chr3:150621326-150621376	HepG2	liver:	n/a
3	chr3:150621326-150621376	GM12892	blood:	n/a
4	chr3:150621326-150621376	HCM	heart:	n/a
5	chr3:150621326-150621376	SKMC	muscle:	n/a
6	chr3:150638295-150638345	NB4	blood:	n/a
7	chr3:150638295-150638345	GM12891	blood:	n/a
8	chr3:150638295-150638345	HNPCEpiC	eye:	n/a
9	chr3:150638295-150638345	HEK293	kidney:	embryo
10	chr3:150621326-150621376	HUVEC	blood vessel:	n/a
11	chr3:150621326-150621376	Hela-S3	cervix:	n/a
12	chr3:150621326-150621376	GM06990	blood:	n/a
13	chr3:150638295-150638345	Hepatocyte	liver:	n/a
14	chr3:150638295-150638345	RPTEC	kidney:	n/a
15	chr3:150638295-150638345	SK-N-SH_RA	brain:	n/a
16	chr3:150638295-150638345	NHBE	bronchial:	n/a
17	chr3:150638295-150638345	ECC-1	luminal epithelium:	n/a
18	chr3:150621326-150621376	RPTEC	kidney:	n/a
19	chr3:150638295-150638345	HCPEpiC	choroid plexus:	n/a
20	chr3:150621326-150621376	PFSK-1	brain:	n/a
21	chr3:150621326-150621376	PrEC	prostate:	n/a
22	chr3:150621326-150621376	GM19239	blood:	n/a
23	chr3:150621326-150621376	ovcar-3	ovarian:	n/a
24	chr3:150638295-150638345	GM06990	blood:	n/a
25	chr3:150638295-150638345	AG09309	skin:	n/a
26	chr3:150638295-150638345	MCF-7	breast:	n/a
27	chr3:150638295-150638345	SK-N-SH	brain:	n/a
28	chr3:150621326-150621376	HRE	kidney:	n/a
29	chr3:150638295-150638345	PrEC	prostate:	n/a
30	chr3:150638295-150638345	T-47D	breast:	n/a
31	chr3:150638295-150638345	CMK	blood:	n/a
32	chr3:150621326-150621376	HMEC	breast:	n/a
33	chr3:150638295-150638345	MCF10A-Er-Src	breast:	n/a
34	chr3:150638295-150638345	IMR90	lung:	fetal
35	chr3:150638295-150638345	U87	brain:	n/a
36	chr3:150621326-150621376	HCT-116	colon:	n/a
37	chr3:150638295-150638345	A549	lung:	n/a
38	chr3:150621326-150621376	HIPEpiC	eye:	n/a
39	chr3:150638295-150638345	PFSK-1	brain:	n/a
40	chr3:150621326-150621376	AG09319	gingival:	n/a
41	chr3:150638295-150638345	AoSMC	blood vessel:	n/a
42	chr3:150621326-150621376	SK-N-MC	brain:	n/a
43	chr3:150621326-150621376	MCF-7	breast:	n/a
44	chr3:150621326-150621376	AG10803	skin:	n/a
45	chr3:150621326-150621376	SK-N-SH	brain:	n/a
46	chr3:150621326-150621376	HNPCEpiC	eye:	n/a
47	chr3:150621326-150621376	AG04450	lung:	fetal
48	chr3:150621326-150621376	AoSMC	blood vessel:	n/a
49	chr3:150621326-150621376	NT2-D1	testis:	n/a
50	chr3:150638295-150638345	Jurkat	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:150617220..150619793-chr3:150619915..150623246,3	MCF-7	breast:
2	chr3:150618519..150622479-chr3:150624058..150626415,3	K562	blood:
3	chr3:150614748..150616518-chr3:150617280..150620214,2	K562	blood:
4	chr3:150478330..150480784-chr3:150625078..150627756,3	MCF-7	breast:
5	chr3:150623156..150625349-chr3:150626620..150628452,2	MCF-7	breast:
6	chr3:150641035..150643742-chr3:150654754..150657787,3	MCF-7	breast:
7	chr3:150622090..150624886-chr3:150628966..150632795,3	MCF-7	breast:
8	chr3:150622090..150624886-chr3:150628966..150632795,3	MCF-7	breast:
9	chr3:150627920..150630352-chr3:150630947..150632626,2	K562	blood:
10	chr3:150615182..150618213-chr3:150621326..150624872,3	K562	blood:
11	chr3:150615265..150617813-chr3:150619650..150621718,2	MCF-7	breast:
12	chr3:150614748..150616518-chr3:150617280..150620214,2	K562	blood:
13	chr3:150624732..150627491-chr3:150803111..150805628,2	MCF-7	breast:
14	chr3:150635212..150636837-chr3:150639555..150642530,2	K562	blood:
15	chr3:150626529..150628111-chr3:150637179..150639956,2	MCF-7	breast:
16	chr3:150623156..150625349-chr3:150626620..150628452,2	MCF-7	breast:
17	chr3:150626529..150628111-chr3:150637179..150639956,2	MCF-7	breast:
18	chr3:150627920..150630352-chr3:150630947..150632626,2	K562	blood:
19	chr3:150615182..150618213-chr3:150621326..150624872,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM188B2-1	chr3:150621036-150621181	XLOC_003285
2	lnc-MED12L-2	chr3:150609833-150610167	XLOC_002874
3	lnc-FAM188B2-1	chr3:150618941-150619243	XLOC_003285

Variant related genes	Relation type
FAM188B2	TF binding region
ENSG00000244382	TF binding region
ENSG00000222079	TF binding region
FAM188B2	CpG island
ENSG00000244382	CpG island
ENSG00000222079	CpG island
ENSG00000222079	chromatin interactions
ENSG00000144893	chromatin interactions
ENSG00000244265	chromatin interactions
ENSG00000244382	chromatin interactions
BCL2	miRNA target sites

Extended variants
information (count: 1316 )
Associated
traits (count: 50 )

Variant overlapped rSNPs/rCNVs (count:1316 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6781075	chr3:150609694-150609695	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs370509956	chr3:150609706-150609707	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs567274240	chr3:150609764-150609765	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs116650340	chr3:150609767-150609768	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs372779739	chr3:150609775-150609776	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs546749877	chr3:150609802-150609803	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs374812346	chr3:150609822-150609823	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs536631720	chr3:150609846-150609847	Enhancers Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
9	rs6768408	chr3:150609866-150609867	Enhancers Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs113104105	chr3:150609867-150609868	Enhancers Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs628383	chr3:150609925-150609926	Enhancers Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs10935821	chr3:150609944-150609945	Enhancers Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
13	rs369764216	chr3:150609957-150609958	Enhancers Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs138950273	chr3:150609972-150609973	Enhancers Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
15	rs192938006	chr3:150610025-150610026	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
16	rs574013393	chr3:150610054-150610055	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
17	rs542590503	chr3:150610056-150610057	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
18	rs559467540	chr3:150610077-150610078	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
19	rs572990992	chr3:150610079-150610080	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
20	rs185533478	chr3:150610084-150610085	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
21	rs565477973	chr3:150610111-150610112	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
22	rs73003596	chr3:150610163-150610164	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs111448113	chr3:150610173-150610174	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs377188504	chr3:150610198-150610199	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs78841045	chr3:150610212-150610213	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs529718928	chr3:150610218-150610219	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs56253143	chr3:150610231-150610232	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs546611579	chr3:150610270-150610271	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs553498710	chr3:150610320-150610321	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs368589374	chr3:150610389-150610390	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs190411882	chr3:150610401-150610402	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs552276893	chr3:150610427-150610428	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs569049996	chr3:150610455-150610456	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs537628330	chr3:150610470-150610471	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs554877583	chr3:150610497-150610498	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs568262903	chr3:150610498-150610499	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs559127842	chr3:150610522-150610523	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs371932083	chr3:150610529-150610530	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs577765397	chr3:150610544-150610545	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs536287089	chr3:150610547-150610548	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs149246637	chr3:150610549-150610550	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs35470998	chr3:150610569-150610570	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs386398233	chr3:150610583-150610584	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs58400247	chr3:150610584-150610585	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs371788034	chr3:150610585-150610586	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs572854871	chr3:150610596-150610597	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs191426250	chr3:150610600-150610601	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs183911693	chr3:150610616-150610617	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs144427950	chr3:150610628-150610629	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs529621276	chr3:150610632-150610633	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:50)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	16773561	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Myelofibrosis	22110671	CNVD
Uveal melanoma	20484589	CNVD

Chromatin state (count:146 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:150605400-150610400	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr3:150606200-150610200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
3	chr3:150606200-150611400	Enhancers	Placenta	Placenta
4	chr3:150607400-150610400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr3:150607800-150610000	Active TSS	Primary B cells from cord blood	blood
6	chr3:150609200-150610200	Enhancers	Monocytes-CD14+_RO01746	blood
7	chr3:150609200-150614400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr3:150610200-150611000	Enhancers	Primary neutrophils fromperipheralblood	blood
9	chr3:150610400-150615800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr3:150611000-150612000	Weak transcription	Primary neutrophils fromperipheralblood	blood
11	chr3:150612000-150612600	Enhancers	Primary neutrophils fromperipheralblood	blood
12	chr3:150612200-150613000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr3:150612600-150615800	Weak transcription	Primary neutrophils fromperipheralblood	blood
14	chr3:150614400-150614600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr3:150614400-150618200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr3:150614600-150618000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr3:150614800-150615000	Bivalent Enhancer	HSMMtube	muscle
18	chr3:150615000-150615200	Bivalent Enhancer	Fetal Lung	lung
19	chr3:150615000-150617800	Enhancers	Fetal Muscle Leg	muscle
20	chr3:150615200-150617000	Enhancers	Fetal Lung	lung
21	chr3:150615800-150616000	Enhancers	Primary neutrophils fromperipheralblood	blood
22	chr3:150615800-150617400	Enhancers	HSMMtube	muscle
23	chr3:150615800-150618000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr3:150616000-150616400	Weak transcription	Primary neutrophils fromperipheralblood	blood
25	chr3:150616200-150618000	Enhancers	Primary hematopoietic stem cells	blood
26	chr3:150616400-150617000	Enhancers	Primary neutrophils fromperipheralblood	blood
27	chr3:150616600-150617600	Enhancers	Primary hematopoietic stem cells short term culture	blood
28	chr3:150616800-150617000	Enhancers	Monocytes-CD14+_RO01746	blood
29	chr3:150616800-150617800	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr3:150617000-150617400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
31	chr3:150617000-150617600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
32	chr3:150617200-150617600	Enhancers	Fetal Muscle Trunk	muscle
33	chr3:150617400-150618000	Enhancers	Monocytes-CD14+_RO01746	blood
34	chr3:150617400-150618200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr3:150617400-150618200	Bivalent Enhancer	HSMMtube	muscle
36	chr3:150617600-150618400	Enhancers	Primary neutrophils fromperipheralblood	blood
37	chr3:150617800-150618200	Enhancers	Fetal Brain Female	brain
38	chr3:150617800-150619800	Weak transcription	Fetal Muscle Leg	muscle
39	chr3:150618000-150618200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
40	chr3:150618000-150618200	Bivalent/Poised TSS	Pancreatic Islets	Pancreatic Islet
41	chr3:150618200-150618400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr3:150619000-150632000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr3:150619800-150620600	Enhancers	Fetal Muscle Leg	muscle
44	chr3:150620400-150621400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
45	chr3:150621000-150621600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
46	chr3:150621000-150621600	Enhancers	HepG2	liver
47	chr3:150621400-150626400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
48	chr3:150621600-150622000	Bivalent Enhancer	Fetal Lung	lung
49	chr3:150624600-150628800	Weak transcription	Fetal Heart	heart
50	chr3:150626600-150626800	Enhancers	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links